The human intestine, colonized by a dense community of resident microbes, is a frequent target of bacterial pathogens. Undisturbed, this intestinal microbiota provides protection from bacterial infections. Conversely, disruption of the microbiota with oral antibiotics often precedes the emergence of several enteric pathogens 1-4 . How pathogens capitalize upon the failure of microbiota-afforded protection is largely unknown. Here we show that two antibioticassociated pathogens, Salmonella enterica serovar Typhimurium (S. typhimurium) and Clostridium difficile, use a common strategy of catabolizing microbiota-liberated mucosal carbohydrates during their expansion within the gut. S. typhimurium accesses fucose and sialic acid within the lumen of the gut in a microbiota-dependent manner, and genetic ablation of the respective catabolic pathways reduces its competitiveness in vivo. Similarly, C. difficile expansion is aided by microbiota-induced elevation of sialic acid levels in vivo. Colonization of gnotobiotic mice with a sialidase-deficient mutant of Bacteroides thetaiotaomicron, a model gut symbiont, reduces free sialic acid levels resulting in C. difficile downregulating its sialic acid catabolic pathway and exhibiting impaired expansion. These effects are reversed by exogenous dietary administration of free sialic acid. Furthermore, antibiotic treatment of conventional mice induces a spike in free sialic acid and mutants of both Salmonella and C. difficile that are unable to catabolize sialic acid exhibit impaired expansion. These data show that antibiotic-induced disruption of the resident microbiota and subsequent alteration in mucosal carbohydrate availability are exploited by these two distantly related enteric pathogens in a similar manner. This insight suggests new therapeutic approaches for preventing diseases caused by antibiotic-associated pathogens.
The human intestine, colonized by a dense community of resident microbes, is a frequent target of bacterial pathogens. Undisturbed, this intestinal microbiota provides protection from bacterial infections. Conversely, disruption of the microbiota with oral antibiotics often precedes the emergence of several enteric pathogens [1] [2] [3] [4] . How pathogens capitalize upon the failure of microbiota-afforded protection is largely unknown. Here we show that two antibioticassociated pathogens, Salmonella enterica serovar Typhimurium (S. typhimurium) and Clostridium difficile, use a common strategy of catabolizing microbiota-liberated mucosal carbohydrates during their expansion within the gut. S. typhimurium accesses fucose and sialic acid within the lumen of the gut in a microbiota-dependent manner, and genetic ablation of the respective catabolic pathways reduces its competitiveness in vivo. Similarly, C. difficile expansion is aided by microbiota-induced elevation of sialic acid levels in vivo. Colonization of gnotobiotic mice with a sialidase-deficient mutant of Bacteroides thetaiotaomicron, a model gut symbiont, reduces free sialic acid levels resulting in C. difficile downregulating its sialic acid catabolic pathway and exhibiting impaired expansion. These effects are reversed by exogenous dietary administration of free sialic acid. Furthermore, antibiotic treatment of conventional mice induces a spike in free sialic acid and mutants of both Salmonella and C. difficile that are unable to catabolize sialic acid exhibit impaired expansion. These data show that antibiotic-induced disruption of the resident microbiota and subsequent alteration in mucosal carbohydrate availability are exploited by these two distantly related enteric pathogens in a similar manner. This insight suggests new therapeutic approaches for preventing diseases caused by antibiotic-associated pathogens.
The intestinal microbiota is composed of trillions of microbial cells that together form a complex, dynamic and highly competitive ecosystem 5, 6 . Limited nutrients and high microbial densities are likely to have a key role in protecting the host against invading microbes 7 . Carbohydrates derived from diet or host play a well-established part in sustaining the resident members of the microbiota [8] [9] [10] , and more recently have been shown to have important roles in gut microbiota-pathogen dynamics [11] [12] [13] [14] .
Oral antibiotic use is one of the leading risk factors for disease associated with Salmonella spp. and Clostridium difficile, consistent with increased enteric vulnerability upon disruption of the resident microbiota [1] [2] [3] [4] 15 . In addition, mouse models of S. typhimurium or C. difficile infection commonly require disruption of the intestinal microbiota with antibiotics to promote pathogen expansion within the lumen of the gut and to initiate disease [16] [17] [18] [19] . Deciphering the numerous mechanisms by which the microbiota prevents bacterial pathogen expansion and how microbiota disruption enables pathogens to circumvent these mechanisms remains an important task.
We used transcriptional profiling of Salmonella typhimurium from orally infected gnotobiotic mice to gain insight into the pathogen's biology while inhabiting the gastrointestinal tract. Our goal was to reveal adaptations of the pathogen within a 'low-complexity' gnotobiotic microbiota that might be relevant to antibiotic-induced microbiota disruption. Mice that were monoassociated with the model gut symbiont Bacteroides thetatiotaomicron (Bt) were used as a simplified model of a microbiota that is susceptible to pathogen emergence within the gut. Five days after S. typhimurium infection of the Bt-monoassociated or germ-free mice ( Fig. 1a ), caecal contents were collected and subjected to transcriptional profiling using a custom S. typhimurium Gene Chip.
In the presence of Bt, all 59 S. typhimurium genes that displayed significantly altered expression relative to infection of germ-free mice were upregulated ( Supplementary Table 1 ). Functional classification of these genes revealed enriched cluster of orthologous groups (COG) categories: 'carbohydrate metabolism and transport' and 'secondary metabolites biosynthesis, transport, and catabolism' ( Supplementary Fig. 2 ). Genes encoding host mucin carbohydrate metabolism pathways are prominently represented in this gene set, including three operons encoding catabolic pathways for sialic acid, fucose and the fucose catabolite propanediol (nan, fuc and pdu, respectively) ( Fig. 1b ). We surveyed expression of genes within the nan and fuc operons 1 day after S. typhimurium infection in germ-free or Bt-monoassociated mice, to determine whether these operons identified by expression profiling on day 5 post infection also display high expression earlier in the infection. S. typhimurium nanE and fucI are significantly upregulated 1 day after infection of Btmonoassociated mice relative to infection of germ-free mice (nanE, 6.0-fold, P 5 1.47 3 10 25 ; fucI, 3.5-fold, P 5 0.0028) ( Fig. 1c ) when S. typhimurium densities and host pathology are similar between colonization states ( Supplementary Figs 3 and 4 ). These data are consistent with S. typhimurium catabolizing sialic acid and fucose in the lumen of the gut in a Bt-dependent manner soon after infection.
We next constructed mutant strains of S. typhimurium to quantitatively assess the requirement of sialic acid and fucose during expansion in vivo. Deletion of nanA and fucI, the first committed steps in the sialic acid and fucose utilization pathways, abolished growth of the strains on the respective sugars ( Supplementary Fig. 5 ). In competition experiments, Bt-monoassociated mice co-infected with wild-type S. typhimurium and a nanA/fucI double mutant strain (St-DnanADfucI) revealed that the mutant had a significant disadvantage on days 1 and 2 after infection (day 1, competitive index (CI)5 1.87, P 5 0.028; day 2, CI 5 1.45, P 5 0.016; Fig. 1d ). This mutant, however, displayed no competitive disadvantage when competing with wild-type S. typhimurium within germ-free mice, consistent with S. typhimurium's sialic acid and fucose use being microbiota-dependent (day 1, P 5 0.26). The competitive index was not significantly different between the two colonization conditions ( Supplementary Fig. 5 ), however this is probably because of the small amount of free sialic acid present in the germ-free mouse gut (see Fig. 2a ).
C. difficile possesses a sialic acid catabolic operon, like S. typhimurium, but encodes no apparent genes for fucose consumption (Supplementary Fig. 6 ). To identify whether C. difficile also expresses sialic acid catabolism genes during its expansion within the gut, we quantified the expression of two genes within the nan operon, nanE and nanA, by quantitative PCR with reverse transcription (qRT-PCR) of RNA extracted from gnotobiotic mouse caecal contents. C. difficile nanE and nanA displayed elevated expression in Bt-monoassociated mice relative to expression levels observed when C. difficile colonized germ-free mice alone (nanE, 15-fold higher expression, P 5 0.02; nanA 11-fold higher expression, P 5 0.039; Fig. 1e ). The presence of Bt in the gut of gnotobiotic mice resulted in an increased density of C. difficile one day post infection compared to infection of germ-free mice (1.5 3 10 8 versus 7.9 3 10 8 colony-forming units (c.f.u.) ml 21 ; P 5 0.0009; Fig. 1f ).
Many commensal and pathogenic bacteria can utilize sialic acids from their hosts as a source of energy, carbon and nitrogen 20 . However, some bacteria, such as B. thetatiotaomicron encode the sialidase required to cleave and release this terminal sugar from the mucosal glycoconjugates, but lack the catabolic pathway (that is, the nan operon) required to consume the liberated monosaccharide. Presumably, the release of sialic acids allows B. thetatiotaomicron to access highly coveted underlying carbohydrates in the mucus 10, 21 . Conversely, S. typhimurium and C. difficile encode the nan operon but each lacks the sialidase required for sialic acid liberation 22, 23 .
We quantified levels of free sialic acids in the caeca of Bt-monoassociated and germ-free mice. Bt-monoassociated mice exhibited a significantly higher concentration of the common sialic acid N-acetylneuraminic acid (Neu5Ac) versus germ-free mice, consistent with the ability of Bt to liberate but not consume the monosaccharide (1059 pmoles mg 21 , Bt-associated; 188 pmoles mg 21 , germ-free; P 5 0.029; Fig. 2a ). Colonization of mice with Bt-DBT0455 (a mutant strain of Bt lacking a predicted cell surface sialidase that achieves the same density as wild type in vivo; Supplementary Fig. 7 ) did not result in increased free sialic acid, Postinfection In germ-free mice in vitro + Bt 
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nor did colonization with Bacteroides fragilis (Bf), which encodes both a sialidase and the nan operon and is therefore able to catabolize Neu5Ac ( Fig. 2a ). Expression of S. typhimurium's nan operon was reduced upon infection of gnotobiotic mice colonized with Bt-DBT0455 or B. fragilis, consistent with S. typhimurium's dependence upon elevated levels of microbiota liberated sialic acid (Fig. 2b) . Loss of Bt-liberated sialic acid affects C. difficile in a manner similar to that observed with S. typhimurium. The nan gene expression in C. difficile was lower in mice colonized with the sialidase-deficient mutant Bt-DBT0455 relative to expression in the presence of Bt-colonized mice (nanE, 75-fold higher expression, P 5 0.0187; Fig. 2c ). Furthermore, C. difficile density decreased in infected mice colonized with Bt-DBT0455 mutant relative to densities in mice colonized with wild-type Bt (9.7 3 10 7 versus 4.6 3 10 8 c.f.u. ml 21 ; P 5 0.0143), illustrating the importance of Bt-liberated sialic acid in C. difficile expansion in vivo ( Fig. 2d ; Supplementary Fig. 8 ). Free sialic acid was orally administered to Bt-DBT0455 and C. difficile co-colonized mice to determine if exogenous administration of the monosaccharide could reverse the decrease in C. difficile density by complementing the sialidase deficiency in this model. C. difficile densities increased 1 day post infection in Bt-DBT0455 monoassociated mice fed free sialic acid compared to unsupplemented controls (4.8 3 10 8 versus 6.8 3 10 7 c.f.u. ml 21 ; P 5 0.0066) reaching densities similar to those observed in the presence of wild type ( Fig. 2e ). Furthermore, expression of C. difficile nanE increases in the sialic acid fed Bt-DBT0455-associated mice, further demonstrating that sialic acid use by C. difficile occurs concomitant with its increased densities in vivo (nanE, 58-fold higher expression over PBS buffer treated controls, P 5 0.019; Fig. 2f ). Notably, free sialic acid administration to germ-free mice infected with C. difficile resulted in higher densities of the pathogen in the lumen of the gut, confirming the important role of this monosaccharide in vivo ( Supplementary Fig. 9 ). These data demonstrate that sialic acid catabolism by C. difficile promotes higher densities of the pathogen and depends upon the availability of the liberated monosaccharide within the lumen of the gut.
To determine whether sialic acid use is relevant to pathogen proliferation in an antibiotic-treated complex microbiota, we quantified free sialic acids in the caeca of conventional mice before and after antibiotic treatment. Levels of free Neu5Ac were very low within untreated conventional mice, consistent with efficient partitioning of Neu5Ac between members of an undisturbed complex microbiota (Fig. 3a) . However, antibiotic-treated mice exhibited elevated levels of free sialic acid 1 day after treatment (725 pmoles mg 21 , 1 day post streptomycin, compared to 17 pmoles mg 21 in untreated mice; P 5 0.0019), a time frame that coincides with pathogen expansion and acute microbiota disturbance ( Supplementary Fig. 10 ) 24 . The pool of free sialic acids decreased by day 3 post treatment, consistent with recovery of the microbiota after antibiotic treatment 24 (Fig. 3a) . St-DnanA and St-DnanADfucI mutants both showed a competitive defect relative to wild-type S. typhimurium 1 day after infection in antibiotic-treated conventional mice (St-DnanA, CI 5 1.83 P 5 0.0095; St-DnanADfucI, CI 5 2.77, P 5 0.036), consistent with sialic acid and fucose utilization providing an advantage to S. typhimurium during emergence (Fig. 3b ). The lack of statistical significance of the phenotype in the fucI single mutant suggests mechanisms that are compensatory for fucose catabolism in this experimental model ( Supplementary Fig. 11 ). To test whether C. difficile relies upon sialic acid catabolism in post-antibiotic expansion, we quantified the expression of the nan operon in antibiotictreated conventional mice 1 day post infection. Coincident with expansion of C. difficile, the nan operon was highly induced compared to basal expression in vitro (nanA, 230-fold, P 5 0.0358; nanT, 112-fold, P 5 0.0217) confirming that C. difficile expresses this operon at high levels during its post-antibiotic expansion within a complex microbiota (Fig. 3c) . As a test of sialic acid catabolism importance in C. difficile proliferation, we constructed a nanT mutant strain of C. difficile (Cd-nanT 2 ) that is deficient in sialic acid consumption ( Supplementary  Fig. 4 ). Cd-nanT 2 was significantly compromised in post-antibiotic expansion of conventional mice relative to wild-type C. difficile (3.1 3 10 7 versus 7.0 3 10 7 c.f.u. ml 21 ; P 5 0.0023) demonstrating the importance of sialic acid catabolism to C. difficile in attaining high densities in the context of an antibiotic-disrupted complex microbiota (Fig. 3d ).
Recent studies have illustrated that enteric bacterial pathogens can subvert aspects of host inflammation to hold potential competitors within the microbiota at bay and enable pathogen proliferation 7, [25] [26] [27] .
Our results indicate that the antibiotic-associated pathogens S. typhimurium and C. difficile exploit increases in mucosal carbohydrate availability that occur upon disruption of the competitive ecosystem in which nutrients are typically efficiently consumed by endogenous community members. The transient post-antibiotic increase in monosaccharides liberated by the resident microbiota from host mucus provides a window of opportunity for these pathogens to expand to densities sufficient to induce self-promoting host inflammation (Supplementary Fig. 1 ). Implicit in these findings are new potential therapeutic strategies to combat post-antibiotic pathogen expansion.
METHODS SUMMARY
Bacterial strains and culture conditions. Strains were grown as follows: B. thetaiotaomicron (VPI-5482), TYG; S. typhimurium (SL1344), LB; C. difficile (630), RCM. For strains and primers see Supplementary Table 2 . 
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Mice. Germ-free Swiss-Webster mice were maintained in gnotobiotic isolators, in accordance with A-PLAC, the Stanford IACUC. Conventional Swiss-Webster mice (SWRF, Taconic) were used for antibiotic-treated experiments. Expression analyses. S. typhimurium transcriptomics in caecal contents were conducted using custom-made GeneChips. Robust multi-chip average-multi-species (RMA-MS) normalized signals were analysed for significant differences using significance analysis of microarrays (SAM). For primers see Supplementary Table 3 . Quantification of sialic acids. Free sialic acids were isolated from caecal content supernatants using a 1K MWCO filter and subjected to 1,2-diamino-4, 5-methylenedioxybenzene (DMB) derivatization before HPLC analysis. 
METHODS
Bacterial strains and culture conditions. B. thetaiotaomicron (ATCC 29148, also known as VPI-5482), was grown anaerobically (6% H 2 , 20% CO 2 , 74% N 2 ) overnight in TYG medium (1% tryptone, 0.5% yeast extract, 0.2% glucose, w/v) supplemented with 100 mM potassium phosphate buffer, pH 7. All strains of S. typhimurium were derived from wild-type strain SL1344, which is naturally streptomycin-resistant. Using the methods of Datsenko and Wanner 28 , mutant strains were first constructed in strain LT2, verified by PCR and then transduced into SL1344 using P22 phage transduction. Mutant strains and primers used in their generation are listed in Supplementary Table 2 . Growth defects were not observed on glucose for either mutant and the presence of sialic acid did not pose a toxicity issue with the nanA mutant as has been previously reported for E. coli 29 , consistent with its polarity that compromises nanT expression (Supplementary Fig. 5e ). For colonization experiments, S. typhimurium strains were grown in Luria-Bertani (LB) broth at 37 uC with aeration or on LB agar plates, with the appropriate antibiotics (200 mg ml 21 streptomycin, 30 mg ml 21 kanamycin). Minimal medium used for transcriptional profiling consisted of 100 mM KH 2 PO 4 , pH 7.2, 15 mM NaCl, 8.5 mM (NH 4 ) 2 SO 4 , 4 mM L-cysteine, 1.9 mM haematin plus 200 mM L-histidine, 100 mM MgCl 2 , 1.4 mM FeSO 4 , 50 mM CaCl 2 , 1 mg ml 21 vitamin K 3 , 5 ng ml 21 vitamin B 12 and 0.5% glucose (w/v). For evaluation of growth on various monosaccharides, strains were grown in M9 minimal media supplemented with 0.02% w/v histidine. Faecal densities (c.f.u.) of S. typhimurium were quantified by duplicate sampling with 1 ml loops, and subsequent dilution and spot plating on plain LB agar for gnotobiotic experiments and LB agar with streptomycin for conventional experiments.
C. difficile strain 630 was used in all C. difficile experiments and was cultured in reinforced clostridial medium (RCM) plus cysteine (Becton Dickinson) anaerobically (6% H 2 , 20% CO 2 , 74% N 2 ). C. difficile growth curves were generated using minimal medium composed of ammonium sulphate, sodium carbonate, calcium chloride, magnesium chloride, manganese chloride, cobalt chloride, histidine hematin, vitamin B 12 , vitamin K 1 , FeSO 4 and 1% Bacto Tryptone diluted 1:1 with 1% or 0.5% carbon source. D 600 nm (OD 600 ) was monitored using a BioTek PowerWave 340 plate reader (BioTek, Winooski, VT) every 30 min, at 37uC anaerobically (6% H 2 , 20% CO 2 , 74% N 2 ). Faecal densities (c.f.u.) of C. difficile were quantified by duplicate sampling with 1 ml loops and subsequent dilution and spot plating on brain heart infusion agar (Becton Dickinson) with 10% v/v of defibrinated horse blood (Lampire Biological Laboratories) supplemented with 25 mg l 21 erythromycin. For quantification of C. difficile c.f.u. in conventional mice, 1 ml of faeces was serially diluted in PBS and plated onto CDMN plates, composed of C. difficile agar base (Oxoid) with 7% v/v of defibrinated horse blood (Lampire Biological Laboratories), supplemented with 32 mg l 21 moxalactam (Santa Cruz Biotechnology) and 12 mg l 21 norfloxacin (Sigma-Aldrich). Plates were incubated overnight at 37 uC in an anaerobic chamber (Coy). Colonies identified as C. difficile were validated by colony PCR.
To construct the nanT null mutant (Cd-nanT 2 ), the ClosTron method for targeted gene disruption in C. difficile and detailed protocol were used 30, 31 . SOEing PCRs with primers IBS, EBS1d, EBS2 and EBS (see Supplementary Table 2 ) were used to assemble and amplify the product for intron targeting, as outlined in the TargeTron users' manual (Sigma-Aldrich). The retargeting sequence was digested with BsrGI/HindIII and cloned into pMTL007C-E2. The resulting plasmid was transformed into HB101/pRK24 for conjugation into JIR8094 32 (a generous gift from A. Shen) to generate Cd-nanT 2 . Reagents and mice. Germ-free Swiss-Webster mice were maintained in gnotobiotic isolators and fed an autoclaved standard diet (Purina LabDiet 5K67) or a polysaccharide-deficient diet 33 , in accordance with A-PLAC, the Stanford IACUC. All animals were 6-12-weeks of age and both genders were used. For all experiments involving C. difficile colonization of germ-free mice, the diet was switched to polysaccharide-deficient chow one day before inoculation with C. difficile. Conventional Swiss-Webster mice (RFSW, Taconic) were used for S. typhimurium and C. difficile antibiotic-treated experiments. The number of animals per group was chosen as the minimum likely required for conclusions of biological significance, established from prior experience. Randomization was not possible in the gnotobiotic setting and blinding was not applicable.
Conventional mice were orally gavaged with 20 mg streptomycin dissolved in water 24 h before infection and starved 18 h before infection. Mice were infected via oral gavage of 14 h overnight cultures of S. typhimurium resuspended in PBS. For single infections of gnotobiotic mice, 10 8 c.f.u. of S. typhimurium were gavaged. For S. typhimurium competitive index experiments, pure cultures of wild-type and mutant bacteria were diluted to equal densities, mixed in a 1:1 ratio and serial diluted in PBS to a total of 10 3 c.f.u. per 200 ml. Each mouse was orally gavaged with 200 ml of this dilution. Throughout the experiment, faecal samples were taken and dilutions were plated on LB agar plates containing streptomycin, which allows for growth of both the wild-type and mutant strains. Colonies from these plates were then patched onto LB agar plus kanamycin plates to determine the proportion of kanamycin-resistant (mutant) cells. With each sample, the ratio of kanamycinsensitive (wild-type) bacteria to kanamycin-resistant (mutant) bacteria was divided by the kan s /kan r ratio determined from the original inoculum to produce the competitive index. Significance was evaluated using one-sample t-tests with a theoretical mean of 1. All competitive indices were determined for faecal samples with the exception of St-DnanA, which was surveyed in caecal contents.
For C. difficile experiments involving conventional mice, antibiotics were administered in the water for 3 days, starting 6 days before inoculation including: kanamycin (0.4 mg ml 21 ), gentamycin (0.035 mg ml 21 ), colistin (850 U ml 21 ), metronidazole (0.215 mg ml 21 ) and vancomycin (0.045 mg ml 21 ) 19 . Mice were then switched to regular water for 2 days and administered 1 mg of clindamycin by oral gavage 1 day before inoculation with C. difficile. Inoculations were by oral gavage at a density of 10 8 c.f.u. from overnight cultures.
For sialic acid administration experiments, N-acetylneuraminic acid (Calbiochem or Santa Cruz Biotechnology) was administered in the water at a 1% concentration. Additionally, mice were orally gavaged 1 mg of sialic acid twice a day. The amount of sialic acid in the caecal contents were calculated to equal approximately 700 pmoles mg 21 of caecal contents, which mirrors the average concentration of free sialic acids we quantified post antibiotic treatment (725 pmoles mg 21 ). Expression analysis. Genome-wide transcriptional profiling of S. typhimurium was conducted using custom-made Gene Chips, which contain probes for all annotated coding sequences for S. typhimurium LT2. RNA was purified from caecal contents and in vitro culture and complementary DNA (cDNA) was prepared, fragmented and labelled as described 9 .
Gene Chip data were RMA-MS normalized as described 34 and log2 transformed. Statistical significance for differential gene expression was determined using significance analysis of microarrays (SAM) 35 . The delta parameter was adjusted to achieve a false discovery rate (FDR) nearest to 10% and this delta value was used to select significantly-regulated genes.
qRT-PCR analysis was performed on RNA extracted from caecal or faecal contents by phenol-chloroform extraction and bead beating. Superscript II (Invitrogen) was used to convert RNA to cDNA and SYBR Green (ABgene) in a MX3000P thermocycler (Stratagene) was used. Fold changes were normalized to in vitro growths in minimal medium containing 0.5% glucose for C. difficile and LB for S. typhimurium. Quantification of sialic acids. All steps were carried out at 4 uC to minimize enzymatic hydrolysis. Approximately 200 mg of flash-frozen caecal contents were weighed out and resuspended in 400 ml of dH 2 O. Samples were vortexed for 30 min at maximum speed and centrifuged for 15 min at 14,000g in a tabletop centrifuge. The supernatant was stored and the pellet resuspended in an additional 400 ml of dH 2 O. The tubes were vortexed individually until the pellet was dispersed and then all samples were vortexed for 30 min, centrifuged, and supernatants were pooled. This process was repeated once more for a total volume of approximately 1 ml. Then 700 ml of each sample was filtered through a Pall 1K MWCO filter for 9 h at 7,000g. Samples were derivatized with 1,2-diamino-4,5-methylenedioxybenzene (DMB) as described previously 36 . The resulting product was analysed by reverse-phase HPLC using a C18 column (Dionex) at a flow rate of 0.9 ml min 21 , using a gradient of 5% to 11% acetonitrile in 7% methanol. The excitation and emission were 373 and 448 nm, respectively. The DMB-derivatized sialic acids were identified and quantified by comparing elution times and peak areas to known standards. 16S rRNA microbial community composition analysis. Faecal DNA was isolated and amplicons generated of the 16S rRNA V4 region (515F, 806R). Samples were sequenced at the Medical Genome Facility, Mayo Clinic using the MiSeq (Illumina) platform 37 . Data analysis was done using QIIME 38 . Single-end reads were analysed to determine operational taxonomic units (OTUs) at 97% sequence similarity using uclust (http://www.drive5.com/usearch/index.html). Taxonomy was assigned using RDP classifier against the GreenGenes database and a phylogenetic tree was built using FastTree. The OTU table was rarified to a sequencing depth of 900 for each set of samples. Beta diversity was determined using unweighted and weighted UniFrac 39 . Statistical analyses. The Student's t-test was used for statistical calculations; *P , 0.05, **P , 0.01 and ***P , 0.001. Error bars indicate s.e.m. n indicates the number of mice used per condition. Normal distribution was assumed for all data and no deviations were noted. Grubbs' test was used to identify and eliminate statistical outliers.
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